Acute lymphoblastic leukemia has different treatment options depending on the patient’s own condition and the typing, staging, and extent of the disease, and is generally treated with systemic chemotherapy. Acute lymphoblastic leukemia is a heterogeneous disease in terms of pathology and incidence groups, and can develop in different age groups. Its etiology may be related to viruses, chemicals, radiation and genetic factors, and it is mainly characterized by anemia, fever, hemorrhage, enlarged lymph nodes and liver and spleen. Treatment methods are as follows, including general treatment, chemotherapy and other methods. 1. General treatment: prevention and treatment of infection (levofloxacin), component transfusion support, prevention and treatment of hyperuricemia (allopurinol extended-release capsule), and maintenance of nutrition (fatty milk amino acid). 2. Chemotherapy program (1) Induction of remission treatment: commonly used programs include cyclophosphamide + vincristine, vinblastine + zorubicin + levodopa montelukastase and so on. (2) Early intensive treatment: commonly used drugs include cyclophosphamide, 6-mercaptopurine, pembrolizumab, and so on. (3) Consolidation therapy after remission: commonly used drugs include high-dose methotrexate, calcium tetrahydrofolate, 6-mercaptopurine. (4) Maintenance therapy: commonly used drugs include dexamethasone, vincristine, pembrolase, cytarabine, cyclophosphamide, 6-mercaptopurine and so on. 3. Other treatments: including hematopoietic stem cell transplantation, radiation therapy, targeted therapy, cellular immunotherapy and so on. If the diagnosis of acute lymphoblastic leukemia is confirmed, it is recommended to carry out standardized treatment as early as possible to reduce the adverse effects of the disease. All of the above medications should be used under the guidance of a doctor, avoid self-medication.